SCHEMBL7908204

SCHEMBL7908204

C[C@@H]1NC(=O)c2cccc([N+](=O)[O-])c2N[C@@H]1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S100A4 P26447 2/20 0.45
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA7 P43166 1/20 0.42
CA9 Q16790 1/20 0.42
TDP1 Q9NUW8 3/20 0.42
PTPRC P08575 1/20 0.41
KMT2A Q03164 2/20 0.41
MAPT P10636 2/20 0.41
RECQL P46063 1/20 0.41
MCL1 Q07820 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.39
PKM P14618 2/20 0.39
MEN1 O00255 1/20 0.39
TSHR P16473 2/20 0.39
ALDH1A1 P00352 2/20 0.39
GPR35 Q9HC97 1/20 0.38
GAA P10253 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7908209 1.00 S100A4 (0.45) S100A4CA1CA2CA7CA9
SCHEMBL7896207 1.00 S100A4 (0.45) S100A4CA1CA2CA7CA9
SCHEMBL7896203 1.00 S100A4 (0.45) S100A4CA1CA2CA7CA9
SCHEMBL7896197 1.00 S100A4 (0.45) S100A4CA1CA2CA7CA9
SCHEMBL6196680 0.80 TSHR (0.41) S100A4CA1CA2CA7CA9
SCHEMBL31297473 0.80 S100A4 (0.41) S100A4CA1CA2CA7CA9
SCHEMBL6200104 0.80 TSHR (0.41) S100A4CA1CA2CA7CA9
SCHEMBL6196688 0.80 TSHR (0.41) S100A4CA1CA2CA7CA9
SCHEMBL17257605 0.74 TDP1 (0.44) TDP1KMT2AMAPTSMN1; SMN2MEN1
SCHEMBL7903541 0.73 TDP1 (0.40) TDP1SMN1; SMN2TSHRALDH1A1GPR35

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6201119-B1 2,3,4,5-TETRAHYDRO-1H-1,4-BENZODIAZEPIN-9-AMINE COMPOUNDS USEFUL AS INTERMEDIATES TO ANTIVIRALS JANSSEN PHARMACEUTICA N.V. (BE) 2001-03-13 US disclosed
US-5371079-A Administering to inhibit replication of HIV-1 in human cells JANSSEN PHARMACEUTICA N.V. (BE) 1994-12-06 US disclosed
US-5270464-A Anti-HIV-1 tetrahydroimidazo[1,4]benzodiazepin-2-(thi) ones JANSSEN PHARMACEUTICA N.V. (BE) 1993-12-14 US disclosed